View Older Stories View More Recent Stories
-
Alliqua (ALQA) Sells TheraBond 3D Antimicrobial Barrier Systems Product Line; Updates Outlook
-
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook
-
Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results
-
Alliqua (ALQA) Reports Partnership with Partners Capital Group to Provide UltraMIST Customers with New Equipment Financing Programs
-
Alliqua BioMedical, Inc. Announces Partnership with Partners Capital Group to Provide UltraMIST® Customers with New Equipment Financing Programs
-
Alliqua BioMedical, Inc. Reports First Quarter of Fiscal Year 2017 Financial Results
-
Alliqua (ALQA) Announces Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
-
Alliqua BioMedical, Inc. Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
-
Alliqua (ALQA) Reports Prelim. Q1 Revenue of $4.6M
-
Alliqua BioMedical, Inc. Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook; Earnings Conference Call Scheduled for May 9, 2017
-
Alliqua (ALQA) to Present New Data at SAWC
-
Alliqua BioMedical, Inc. to Present New Data at the Spring 2017 Symposium on Advanced Wound Care
-
Alliqua BioMedical (ALQA) Confirms Closing of $3.8M Share Offering
-
Alliqua BioMedical, Inc. Announces Closing of Approximately $3.8 Million Public Offering
-
Alliqua (ALQA) Prices 9.38M Common Stock Offering at $0.40/Share
-
Alliqua BioMedical, Inc. Announces Pricing of Public Offering of Common Stock
-
Alliqua (ALQA) Plans Offering of Common Stock
-
Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock
-
Alliqua (ALQA) Reports Publication of Peer-reviewed Study Examining Use of MIST Therapy for Deep Tissue Pressure Injuries
-
Alliqua BioMedical, Inc. Announces the Publication of a Peer-reviewed Study Examining the Use of MIST Therapy for Deep Tissue Pressure Injuries
-
Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results
-
Alliqua (ALQA) Closes $2.8 Million Private Placement
-
Alliqua BioMedical, Inc. Announces the Closing of Approximately $2.8 Million Private Placement
-
Alliqua (ALQA) Reports Termination of Agreement to Acquire Soluble Systems
-
Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC
-
Alliqua BioMedical, Inc. Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results
-
Alliqua's (ALQA) MIST Therapy System Receives Expanded Medicare Reimbursement Coverage
-
Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for MIST Therapy®
-
Alliqua (ALQA) to Acquire Soluble Systems
-
Alliqua BioMedical, Inc. to Acquire Soluble Systems, LLC
-
Alliqua (ALQA) Offers Prelim. Q3 Results; Sees Revenue Growth of 16%
-
Alliqua BioMedical, Inc. Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th
-
Alliqua BioMedical, Inc. Expands Regenerative Medicine Portfolio with the Commercial Introduction of Interfyl Connective Tissue Matrix
-
Alliqua BioMedical, Inc. Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results
-
Alliqua (ALQA) Enters Agreement for Exclusive SORBION Products Distribution Rights
-
Alliqua BioMedical, Inc. and BSN medical, Inc. Announce Definitive Agreement on Distribution Rights for Sorbion Dressing Products in the U.S., Canada and Latin America; Alliqua Updates Fiscal Year 201
-
Alliqua (ALQA) Prelim. Q2 Revenue Tops Views
-
Alliqua BioMedical, Inc. Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for August 9th
-
Alliqua BioMedical, Inc. Reports First Quarter Financial Results
-
Alliqua BioMedical Presents at the Spring 2016 SAWC Meeting
-
Alliqua BioMedical, Inc. Announces Participation in the Blue Cross Blue Shield Association’s Evidence Street Pilot Program
-
Alliqua (ALQA) Announces Biovance Eligibility for Wisconsin Physicians Service Coverage
-
Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for Biovance®
-
Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2015 Financial Results
-
Alliqua BioMedical Announces Changes to Its Board of Directors
-
Alliqua’s UltraMIST® System Honored With GOOD DESIGN Award
-
Alliqua Biomedical Announces Partnership With Human Longevity Inc., Under Existing Licensing Agreement
-
Alliqua (ALQA) Enters National Group Purchasing Agreement with HealthTrust
-
Alliqua BioMedical Announces Agreement With HealthTrust
-
Alliqua BioMedical, Inc. Reports Third Quarter Financial Results

